NorthCrest Asset Manangement LLC Takes Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

NorthCrest Asset Manangement LLC bought a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 7,572 shares of the company's stock, valued at approximately $651,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of PBH. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth $84,932,000. Raymond James Financial Inc. acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at $42,593,000. Norges Bank bought a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth about $40,009,000. Bessemer Group Inc. lifted its position in Prestige Consumer Healthcare by 10,053.1% in the fourth quarter. Bessemer Group Inc. now owns 295,050 shares of the company's stock worth $23,041,000 after purchasing an additional 292,144 shares during the period. Finally, Natixis Advisors LLC lifted its holdings in shares of Prestige Consumer Healthcare by 1,335.1% in the fourth quarter. Natixis Advisors LLC now owns 209,246 shares of the company's stock valued at $16,340,000 after buying an additional 194,665 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Wall Street Zen upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

PBH traded down $0.08 during midday trading on Wednesday, reaching $83.60. 170,957 shares of the company's stock were exchanged, compared to its average volume of 299,227. The company has a quick ratio of 2.82, a current ratio of 4.20 and a debt-to-equity ratio of 0.55. The business has a 50-day simple moving average of $83.85 and a two-hundred day simple moving average of $82.54. The firm has a market capitalization of $4.13 billion, a price-to-earnings ratio of 19.49, a price-to-earnings-growth ratio of 2.51 and a beta of 0.45. Prestige Consumer Healthcare Inc. has a one year low of $64.63 and a one year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. The firm had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company's quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.02 earnings per share. As a group, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.